Top Pharmaceuticals companies in Canada by EBITDA
Canada
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 5.01 B
|
Dec. 31, 2023 | USD 122.81 | -2.58% |
|
Canada |
|
| 2 |
USD 2.20 B
|
Dec. 31, 2023 | USD 7.49 | 1.16% |
|
Canada |
|
| 3 |
USD 499.00 M
|
Dec. 31, 2023 | USD 17.23 | -0.99% |
|
Canada |
|
| 4 |
USD 125.97 M
|
Dec. 31, 2023 | USD 30.84 | 0.81% |
|
Canada |
|
| 5 |
USD 93.43 M
|
Dec. 31, 2023 | USD 13.41 | 0.42% |
|
Canada |
|
| 6 |
USD 82.07 M
|
Dec. 31, 2023 | USD 23.94 | 0.98% |
|
Canada |
|
| 7 |
USD 30.86 M
|
Dec. 31, 2023 | USD 3.69 | 0.40% |
|
Canada |
|
| 8 |
USD 19.28 M
|
March 31, 2024 | USD 3.11 | 5.40% |
|
Canada |
|
| 9 |
USD 18.60 M
|
Dec. 31, 2023 | USD 1.51 | -0.70% |
|
Canada |
|
| 10 |
USD 15.11 M
|
March 31, 2024 | USD 3.94 | -2.21% |
|
Canada |
|
| 11 |
USD 12.88 M
|
Dec. 31, 2023 | USD 2.70 | 2.33% |
|
Canada |
|
| 12 |
USD 11.26 M
|
Dec. 31, 2023 | USD 9.40 | -4.39% |
|
Canada |
|
| 13 |
USD -2.75 M
|
March 31, 2024 | USD 1.82 | -9.45% |
|
Canada |
|
| 14 |
USD -3.82 M
|
Dec. 31, 2023 | USD 2.82 | -2.42% |
|
Canada |
|
| 15 |
USD -6.13 M
|
Sept. 30, 2024 | USD 1.59 | -8.09% |
|
Canada |
|
| 16 |
USD -6.47 M
|
Dec. 31, 2023 | USD 1.25 | -0.34% |
|
Canada |
|
| 17 |
USD -7.26 M
|
Nov. 30, 2024 | USD 1.93 | -6.31% |
|
Canada |
|
| 18 |
USD -8.20 M
|
Sept. 30, 2024 | USD 4.08 | -3.32% |
|
Canada |
|
| 19 |
USD -8.71 M
|
Oct. 31, 2023 | USD 1.51 | -1.31% |
|
Canada |
|
| 20 |
USD -9.86 M
|
Nov. 30, 2023 | USD 1.71 | 4.46% |
|
Canada |
|
| 21 |
USD -10.40 M
|
Dec. 31, 2023 | USD 0.11 | 0.09% |
|
Canada |
|
| 22 |
USD -13.37 M
|
Dec. 31, 2023 | USD 2.12 | -1.09% |
|
Canada |
|
| 23 |
USD -13.78 M
|
March 31, 2024 | USD 0.91 | -2.78% |
|
Canada |
|
| 24 |
USD -17.44 M
|
Sept. 30, 2024 | USD 1.53 | -2.45% |
|
Canada |
|
| 25 |
USD -21.04 M
|
Dec. 31, 2023 | USD 1.25 | -1.98% |
|
Canada |
|
| 26 |
USD -25.43 M
|
Dec. 31, 2023 | USD 0.82 | -3.10% |
|
Canada |
|
| 27 |
USD -26.73 M
|
Dec. 31, 2023 | USD 3.15 | -5.12% |
|
Canada |
|
| 28 |
USD -26.78 M
|
Dec. 31, 2023 | USD 7.26 | -2.32% |
|
Canada |
|
| 29 |
USD -28.21 M
|
Dec. 31, 2023 | USD 3.02 | 1.15% |
|
Canada |
|
| 30 |
USD -28.45 M
|
Sept. 30, 2024 | USD 1.77 | 2.31% |
|
Canada |
|
| 31 |
USD -45.87 M
|
Dec. 31, 2023 | USD 0.94 | 1.68% |
|
Canada |
|
| 32 |
USD -52.04 M
|
Oct. 31, 2024 | USD 7.58 | -5.96% |
|
Canada |
|
| 33 |
USD -56.84 M
|
Dec. 31, 2023 | USD 1.96 | -0.51% |
|
Canada |
|
| 34 |
USD -58.00 M
|
March 31, 2024 | USD 8.83 | -0.79% |
|
Canada |
|
| 35 |
USD -63.05 M
|
Dec. 31, 2023 | USD 7.55 | -2.83% |
|
Canada |
|
| 36 |
USD -72.84 M
|
May 31, 2024 | USD 1.18 | -0.37% |
|
Canada |
|
| 37 |
USD -92.57 M
|
Dec. 31, 2023 | USD 6.40 | -1.54% |
|
Canada |
|
| 38 |
USD -114.27 M
|
Dec. 31, 2023 | USD 1.27 | -3.05% |
|
Canada |
|
| 39 |
USD -120.70 M
|
Dec. 31, 2023 | USD 13.62 | -2.44% |
|
Canada |
|
| 40 |
USD -192.16 M
|
Dec. 31, 2023 | USD 2.77 | -7.67% |
|
Canada |
|
| 41 |
USD -210.51 M
|
Dec. 31, 2023 | USD 39.65 | 3.66% |
|
Canada |
|
| 42 |
USD -230.93 M
|
March 31, 2024 | USD 2.23 | -6.78% |
|
Canada |
Frequently Asked Questions
-
Which Pharmaceuticals company in Canada has the highest EBITDA ?
The Pharmaceuticals company in Canada with the highest EBITDA is Loblaw Companies Limited (Toronto Stock Exchange: L.TO) at USD 5.01 B.
-
Which Pharmaceuticals company in Canada has the lowest EBITDA ?
The Pharmaceuticals company in Canada with the lowest EBITDA is Canopy Growth Corporation (Toronto Stock Exchange: WEED.TO) at USD -230.93 M.
-
What are the top 10 Pharmaceuticals companies in Canada by EBITDA ?
The top 10 Pharmaceuticals companies in Canada by EBITDA are Loblaw Companies Limited, Bausch Health Companies Inc., Bausch + Lomb Corporation, Andlauer Healthcare Group Inc., Savaria Corporation, Jamieson Wellness Inc., Knight Therapeutics Inc., Medexus Pharmaceuticals Inc., CareRx Corporation and Aurora Cannabis Inc..
-
What are the bottom 10 Pharmaceuticals companies in Canada by EBITDA ?
The bottom 10 Pharmaceuticals companies in Canada by EBITDA are Canopy Growth Corporation, Xenon Pharmaceuticals Inc., AbCellera Biologics Inc., Zymeworks Inc., Repare Therapeutics Inc., Mind Medicine (MindMed) Inc., Tilray Brands, Inc., Aurinia Pharmaceuticals Inc., Cybin Inc. and Milestone Pharmaceuticals Inc..